documents: FDA-1981-N-0042-0011
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1981-N-0042-0011 | FDA | FDA-1981-N-0042 | Lumpkin, M.M. 1993. Microbiology labeling information letter to NDA holders, Division of Anti-Infective Drug Products, Center for Drug Evaluation and Research. re: Comment from Procter & Gamble Company | Supporting & Related Material | Background Material | 2016-08-26T04:00:00Z | 2016 | 8 | 2016-08-26T15:55:27Z | 0 | 0 | 09000064821a0a19 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref